The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
3M CO | COM | 88579Y101 | 12,170,600 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
ARBUTUS BIOPHARMA CORP | COM | 03879J100 | 16,810,061 | 8,280,818 | SH | SOLE | 8,280,818 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 875,125 | 164,807 | SH | SOLE | 164,807 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 7,518,727 | 7,672,170 | SH | SOLE | 7,672,170 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | NOTE 4.000%11/1 | 29664WAB1 | 9,358,127 | 17,275,000 | PRN | SOLE | 17,275,000 | 0 | 0 | ||
HERTZ GLOBAL HLDGS INC | *W EXP 06/30/205 | 42806J148 | 755,783 | 123,494 | SH | SOLE | 123,494 | 0 | 0 | ||
HERTZ GLOBAL HLDGS INC | COM NEW | 42806J700 | 1,068,053 | 87,188 | SH | SOLE | 87,188 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 16,402,358 | 427,256 | SH | SOLE | 427,256 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 3,324,574 | 86,600 | SH | Call | SOLE | 86,600 | 0 | 0 | |
INDIVIOR PLC | ORD | G4766E116 | 315,374,087 | 13,670,312 | SH | SOLE | 13,670,312 | 0 | 0 | ||
META PLATFORMS INC | CL A | 30303M102 | 10,860,097 | 36,175 | SH | SOLE | 36,175 | 0 | 0 | ||
ODYSSEY MARINE EXPL INC | COM NEW | 676118201 | 5,130,809 | 1,371,874 | SH | SOLE | 1,371,874 | 0 | 0 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | 92,449,910 | 7,915,232 | SH | SOLE | 7,915,232 | 0 | 0 | ||
SONOS INC | COM | 83570H108 | 5,243,681 | 406,172 | SH | SOLE | 406,172 | 0 | 0 |